Principal Financial Group Inc Seagen Inc. Transaction History

Principal Financial Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$191.51 - $216.16 $917,332 - $1.04 Million	-4,790 Reduced 2.83%	164,451 $34.9 Million
Q2 2023 Aug 07, 2023	SELL	$187.64 - $206.25 $28.2 Million - $31 Million	-150,357 Reduced 47.05%	169,241 $32.6 Million
Q1 2023 May 09, 2023	SELL	$127.59 - $203.08 $4.66 Million - $7.41 Million	-36,506 Reduced 10.25%	319,598 $64.7 Million
Q4 2022 Feb 09, 2023	BUY	$117.37 - $139.17 $7.45 Million - $8.83 Million	63,454 Added 21.68%	356,104 $45.8 Million
Q3 2022 Nov 09, 2022	BUY	$135.27 - $180.11 $3.76 Million - $5.01 Million	27,826 Added 10.51%	292,650 $40 Million

Q2 2022 Aug 10, 2022	BUY	$108.81 - $179.33 $9.71 Million - $16 Million	89,232 Added 50.82%	264,824 $46.9 Million
Q1 2022 May 09, 2022	BUY	$119.61 - $157.85 $1.66 Million - $2.18 Million	13,839 Added 8.56%	175,592 $25.3 Million
Q4 2021 Feb 09, 2022	SELL	$142.57 - $190.86 $411,171 - $550,440	-2,884 Reduced 1.75%	161,753 $25 Million
Q3 2021 Nov 09, 2021	SELL	$142.45 - $169.82 $343,162 - $409,096	-2,409 Reduced 1.44%	164,637 $28 Million
Q2 2021 Aug 10, 2021	BUY	$135.08 - $161.1 $5.38 Million - $6.41 Million	39,801 Added 31.28%	167,046 $26.4 Million
Q1 2021 May 10, 2021	BUY	$137.51 - $190.8 $868,375 - $1.2 Million	6,315 Added 5.22%	127,245 $17.7 Million
Q4 2020 Feb 08, 2021	BUY	$164.63 - $211.93 $19.9 Million - $25.6 Million	120,930 New	120,930 $21.2 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.